Securities Investigations
ImmunityBio, Inc. (NasdaqGS: IBRX)
ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Super Micro Computer, Inc. (NasdaqGS: SMCI)
Super Micro Computer, Inc. Notice of May 26, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Gartner, Inc. (NYSE: IT)
Gartner, Inc. Securities Fraud Class Action Result of Reduced Guidance Disclosure and 48% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Gemini Space Station, Inc. (NasdaqGS: GEMI)
Gemini Space Station, Inc. Notice of May 18, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Trip.com Group Limited (NasdaqGS: TCOM)
Trip.com Group Limited Securities Fraud Class Action Result of Antitrust Probe and 19% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Driven Brands Holdings Inc. (NasdaqGS: DRVN)
Driven Brands Holdings Inc. Securities Fraud Class Action Result of Erroneous Financial Statements and 39% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Soleno Therapeutics, Inc. (NasdaqCM: SLNO)
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Boston Scientific Corporation (NYSE: BSX)
Boston Scientific Shareholder Alert: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Boston Scientific Corporation – BSX
Apollo Global Management, Inc. (NYSE: APO)
Apollo Global Management, Inc. Securities Fraud Class Action Result of Undisclosed Relationship with Jeffrey Epstein and 16% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Oracle Corporation (NYSE: ORCL)
Oracle Shareholder Alert: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Oracle Corporation – ORCL
Navan, Inc. (NasdaqGS: NAVN)
Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Corcept Therapeutics Incorporated (NasdaqCM: CORT)
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Enphase Energy, Inc. (NasdaqGM: ENPH)
Enphase Energy, Inc. Notice of April 20, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Kyndryl Holdings, Inc. (NYSE: KD)
Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
uniQure N.V. (NasdaqGS: QURE)
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Ultragenyx Pharmaceutical Inc. (NasdaqGS: RARE)
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline